Chalk Talk: Fletcher Biosciences
February 7, 2024
Chalk Talks are back! We're excited to be kicking off the first Chalk Talk of 2024 with Fletcher Biosciences! Fletcher Biosciences was formed by two former postdocs at MIT and HMS, with over five years of prior research collaboration. Together, they are developing precision T-cell therapeutics that leverage the natural language of T-cell communication. Powered by modern protein engineering methods, this approach has led to new opportunities in both oncology and autoimmunity. Enjoy some tasty treats from A4 Cafe while learning more about Fletcher Biosciences with co-founder and CEO, Patrick Holec!